Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials

Authors:
  • KHKarin Hardt
    Karin Hardt
  • BSBart Spiessens
    Bart Spiessens
  • PIPatricia Izurieta
    Patricia Izurieta
  • TVThomas Verstraeten
    Thomas Verstraeten
  • TBThomas Breuer
    Thomas Breuer
  • GDGary Dubin
    Gary Dubin

Abstract
A pooled analysis of the safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine Cervarix™ (GlaxoSmithKline) was performed in a cohort of almost 30000 girls and women...